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ess: aquilescamelier@hSummary This study describes the correlations and reproducibility of AQ20, a
simple health status questionnaire with 20 questions, which was designed to be
useful especially in time sparing situations. A formal language validation process was
done, in order to validate the AQ20 before studying its reproducibility. Thirty stable
COPD patients answered the final version twice within 15 days. To test the
reproducibility of AQ20, the interclass correlation coefficient and Bland–Altman
display were used. Results were correlated with FEV1, SpO2, BMI, Mahler BDI, and the
Saint George Respiratory Questionnaire (SGRQ). Twenty-five patients (83.3%) were
male, with a mean age of 68.6 years. The mean predicted FEV1 (%) was 56.8%. The
interclass correlation ratio for the total score was a ¼ 0:90 for the intraobserver
variability and a ¼ 0:93 for the interobserver variability. The correlation with total
SGRQ score was 0.76, with Po0.001. The mean application time for AQ20 was 4min
and 6 s, and the score calculation time, was 8 s. It can be concluded that AQ20 is
reproducible, with an excellent correlation with SGRQ total score, and also having
the advantage of taking just a few minutes to be applied and to have its score
calculated.
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Chronic obstructive pulmonary disease (COPD) is a
disease state associated with a high degree of
social and physical disability. There is an increasing
awareness for the need to assess health-related
quality of life or health status, however, there
is a weak correlation between physiologicaled.
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instruments (generic and specific health status
questionnaires) have been intensively used in the
clinical trials to assess the patient-oriented impact of
different interventions on COPD.2–6 The use of
standardized questionnaires permits the collection
of health status scores in multinational studies, but
this is only possible if great care is taken in the
linguistic and cultural translation of a questionnaire
from one language to another.7 Another issue with
these questionnaires is that they tend to be rather
long and complex to use and there is a need for
shorter simpler questionnaires where this is possible.8
The AQ20 is a specific questionnaire, for ob-
structive diseases, and it was developed by Quirk
and Jones.9 It has only 20 questions (of yes/no/not
applicable answers), and requires a small amount
of time to answer it and calculate its scores. As far
as we know, there are only five AQ20 studies
previously published in the literature,10–14 and two
of them deals with COPD patients.10,15 A good
correlation of AQ20 and another disease-specific
health status questionnaire, the Saint George
Respiratory Questionnaire (SGRQ; r ¼ 0:86),10 was
shown in COPD patients. In asthmatics, a good
correlation was found with the Asthma Quality of
Life Questionnaire (AQLQ; r ¼ 0:80) as well.11
The objective of this study was to evaluate a
linguistic and cultural translation of a Brazilian
Portuguese version of the AQ20 with respect to: (1)
the reproducibility of AQ20, particularly the inter-
and intra-observer variability; (2) the time spent in
the completion and score calculation; (3) correlations
with other COPD established outcome measurements.Material and methods
Patients:1. Inclusion criteria: Diagnosis of COPD (2003
updated GOLD criteria)14 with clinical stability,
assessed by the five following criteria: lack of
unscheduled hospitalization 30 days before and
during the study; stability of pulmonary symp-
toms, assessed by a standardized questionnaire;
rest SpO2 (%) variation less than 72%; FEV1
variation less than 710%; no change in medica-
tion during the study.2. Exclusion criteria: concomitant pulmonary dis-
eases other than COPD; other comorbidities, or
incapacitant diseases.
The patients were selected in a consecutive
order, from the COPD outpatient clinic at the
Federal University of Sa˜o Paulo, Brazil.Protocol
The study protocol used the Brazilian Portuguese
version of AQ20, previously obtained from a
formal native language translation and back trans-
lation process of the original English version of
AQ20 (Table 1).16 In the translation period, no
substantial modification in the questions were
needed.
The protocol followed similar methods used in
the validation of SGRQ16 and SF-3617 in Brazil, and
is described below in the following paragraphs.
The questionnaires were filled out in a quiet
room, alone, after the AQ20’s instructions were
read by one interviewer. In the illiterate patients,
the questionnaires were read in a loud voice by the
interviewer. The AQ20’s questionnaire and its
instructions are shown in Table 4. The patients
were requested to fill out a form about the
difficulties they had when answering the AQ20.
At the first visit, the following measurements
were taken: body mass index (BMI), spirometry (ATS
standards) and pulse oximetry (SPO2) after 15min
of rest and breathing room air and; on the same day
the AQ20 was applied twice by two different
observers and the patients were required to answer
three other questionnaires: SGRQ, baseline dys-
pnea index (BDI) and the Brazilian Market and
Research Society Questionnaire (SEC),18 to assess
the socioeconomic status.
Reproducibility
To test intra-observer reproducibility, the AQ20 was
applied twice in the same day, by two different
observers in a random order, with no previous
knowledge of the answers of the patients. To test
intra-patient and intraobserver reproducibilities,
after a 15 day interval, the AQ20 was applied a
third time to the same patients, by one of the
observers who had administered the questionnaire
on the first day.
Completion time
The time to complete the AQ20 and SGRQ and
calculation of its scores were measured with a
digital chronometer.
Statistical analysis
The results are shown in mean7SD. Intra-class
correlation coefficient (ICCC) was calculated to
evaluate reproducibility between the same ques-
tionnaires. As the variables presented a non-normal
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Table 1 AQ20 questionnaire’s instructions and questions.
Airways Questionnaire 20
The following questions are concerned with the effect of your chest trouble on your everyday life. Please
respond Yes, No or Not Applicable (N/A) to each item.
Questions Yes No N/A
1. Do you suffer from coughing attacks during the day?
2. Because of your chest trouble do you often feel restless?
3. Because of your chest trouble do you feel breathless
maintaining the garden?
4. Do you worry when going to a friend’s house that there
might be something there that will set off an attack of chest
trouble?
5. Do you suffer from chest symptoms as a result of exposure
to strong smells, cigarette smoke or perfume?
6. Is your partner bothered by your chest trouble?
7. Do you feel breathless while trying to sleep?
8. Do you worry about the long term effects on your health of
the drugs that you have to take because of your chest
trouble?
9. Does getting emotionally upset make your chest trouble
worse?
10. Because of your chest trouble are there times when you
have difficulty getting around the house?
11. Because of your chest trouble do you suffer from
breathlessness carrying out your activities at work?
12. Do you feel breathlessness walking upstairs because of
your chest trouble?
13. Because of your chest trouble do you suffer from
breathlessness doing housework?
14. Because of your chest trouble do you go home sooner
than others after a night out?
15. Because of your chest trouble do you suffer from
breathlessness when you laugh?
16. Because of your chest trouble do you often feel
impatient?
17. Because of your chest trouble do you feel that you cannot
enjoy a full life?
18. Do you feel drained after a cold because of your chest
trouble?
19. Do you have a feeling of chest heaviness?
20. Do you bother much about your chest trouble?
A. Camelier et al.604
ARTICLE IN PRESS
Table 3 Gender, COPD stage (GOLD criteria), rest
oxygen saturation and nutritional status of the 30
COPD patients.
n (%)
Male 25 (83.3)
Illiterate 7 (23.3)
COPD stages (GOLD criteria)
Brazilian version of airways questionnaire 20 605distribution, Spearman correlation coefficient were
calculated to evaluate association between two
ordinal variables. A Po0.05 was considered sig-
nificant. The analyses were performed with the
SPSS 10.0 software.19
The protocol was approved by the University
Ethical Committee and a written informed consent
was obtained from all patients.I (mild) 4 (13.3)
II (moderate) 11 (36.7)
III (severe) 10 (33.3)
IV (very severe) 5 (16.7)
SpO2488% 25 (83.3)
SpO2p88% 5 (16.3)
Obese (BMIX27 kg/h2) 14 (46.6)
Undernourished (BMIo22 kg/h2) 7 (23.4)
Eutrophic (22pBMIo27 kg/h2) 9 (30)Results
The initial sample comprised of 35 patients, but
five were excluded (three patients because of
clinical instability during the study, and two did
not return for the second visit), totaling 30 patients
at the end of the study. The patients’ clinical
characteristics are shown in Table 2. Twenty-five
(83.3%) were male, seven (23.4%) were under-
nourished, fourteen (46.6%) obese and 7 (23.4%)
were illiterate. For the illiterate subjects, the
AQ20 was read in a loud and uniform voice by the
observers, and their answers written down. No
other help was given, to avoid any influence in the
pattern of the answers. The recently updated
GOLD14 classification of COPD and other clinical
characteristics are listed in Table 3. The hypoxemic
patients were receiving continuous domiciliary
oxygen therapy.
There was an excellent intra-observer reprodu-
cibility, with the ICCC for the AQ20 scores
obtained by the same observer 15-days apart of
0.90, Po0.01. When a sub-analysis was made for
the illiterate patients, the ICCC was 0.87 (Po0.01).
A similar value was obtained for the SGRQ
in the same situation (ICCC ¼ 0:89; Po0.01).
The inter-observer variation calculated
for AQ20 scores obtained by two different
observers on the same day was 0.93, Po0.01
and 0.92, Po0.02 for a variation over a 15-day
interval.Table 2 Demographic and pulmonary function
values for the 30 COPD patients evaluated with the
AQ20 questionnaire.
Mean7SD
Age (years) 68.678.5
BMI (kg/m2) 25.774.7
FEV1 (l) 1.26+0.5
FEV1 (%) 56.8723.3
FEV1/FVC 47.1711.0
SpO2 (%) 92.373.5Doubts
All patients filled out a form about the difficulties
they had when answering the AQ20. Twenty-five
patients (83.3%) found that AQ20 had a good size, 3
(10%) found it too short for their necessities, and 2
(6.7%) found it too big. Twenty-eight patients
(93.3%) found AQ20 very easy to answer, and 26
(87.7%) had no doubt in answering it. The questions
referred as doubtfuls were:1. Question 5: one patient wanted to have another
option to answer, beyond yes or no.2. Question 8: one patient did not understand
completely the meaning of this question.3. Question 6: one patient did not know his
partner’s opinion about his chest trouble.4. Question 18: one patient thought he feels
drained after a cold, but not because his chest
troubles.
Construct validity was tested by comparing AQ20
scores with other clinical and functional para-
meters. There was a good correlation with the
total SGRQ score, r ¼ 0:76 (Po0:01), Fig. 1. The
AQ20 score also correlated with the three domains
of SGRQ (symptoms: r ¼ 0:40; Po0:03; activities:
r ¼ 0:67; Po0:01; impact: r ¼ 0:71; Po0:01).
To obtain a more detailed analysis of the
relationship between the long SGRQ and the shorter
AQ20, the patients were divided into two groups
according to the updated GOLD criteria (mild to
moderate: GOLD I and II; severe–very severe: GOLD
III and IV). In the mild to moderate group, the
correlation between AQ20 and SGRQ total score
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Table 4 BDI’s correlations with AQ20 in the two
visits.
1 AQ20
(Observer
1, day 1)
2 AQ20
(Observer
2, day 1)
3 AQ20
(Observer
1, day 15)
1st BDI r ¼ 0:36 r ¼ 0:47 r ¼ 0:40
(Observer
1, day 1)
Po0:05 Po0:01 Po0:03
2nd BDI r ¼ 0:56 r ¼ 0:64 r ¼ 0:44
(Observer
1, day 15)
Po0:01 Po0:01 Po0:02
Figure 1 Spearman’s correlation between AQ20 and
SGRQ total (%) scores.
A. Camelier et al.606was r ¼ 0:54 (Po0:04), and in the severe–very
severe group, r ¼ 0:83 (Po0:01).
When the patients were divided in hypoxemic
(SpO2p88%) and non-hypoxemic,20 the AQ20 and
SGRQ correlations were r ¼ 0:82 (Po0:09) and r ¼
0:64 (Po0:01), respectively.
No gender-related differences were seen for
AQ20 and SGRQ means. The mean7SD for AQ20%
and SGRQ total % score (respectively) for men were
36.80720.10 and 40.29716.75, and for women
were 52.00732.13 and 53.05720.74. No statistical
significant differences were found between the
mean AQ20, SGRQ, age, FEV1%, BDI and SpO2% when
the sample was divided according to gender (P
values, respectively: 0.17; 0.15; 0.45; 0.21 and
0.84).
There was a modest correlation between
AQ20 and breathlessness measured with the BDI
(Table 4), but we also noted that the repeatability
of the BDI over 15 days was quite weak ICCC ¼ 0:37
(Po0:01).
The AQ20 took 4.171.3min to be completed,
compared to the SGRQ, which required
13.0674.8min. On average it required only 8 s to
manually calculate the score the AQ20 compared to
3.8min for the SGRQ.Discussion
The objective of this study was to analyse the
reproducibility and construct validity of a Portu-
guese translation of the AQ20, an obstructive
disease-specific health status questionnaire inBrazilian COPD patients, once that no substantial
modifications in the AQ20 were necessary in the
process of validation and cultural adaptation to the
Brazilian language (Portuguese).16 Several health
status questionnaires have been described in the
literature, but the majority of them are time-
consuming, which may limit their use. There are
only five published studies evaluating the AQ20
properties, just one of them in COPD patients.9–13
As far as we know, this is the first study that
measured and compared the time spent for the
application and calculation of the AQ20 and SGRQ
scores. The AQ20 required less than 5min to be
completed and calculated. This was due to the
simplicity of its questions and scoring system. The
simplicity of the questionnaire also meant that it
needed little modification to be appropriate to
Brazilian patients.
There was a good intra-class correlation for the
AQ20 scores obtained by two different observers.
This was well above the minimal intra-class
correlation coefficient value of X0.75 accepted
for the demonstration of the reproducibility of a
new questionnaire.21,22 All correlation coefficients
found in this study were equal or superior to 0.90.
As Brazil is a developing country, and part of the
population is still illiterate, 7 patients selected for
the study had this condition, but a similar ICCC
value (ICCC ¼ 0:87; Po0:01) was seen, showing that
reading the questions from a simple health status
questionnaire for this sample did not interfere with
its reproducibility.
We found a reasonable level of correlation
between the AQ20 and the SGRQ domain scores.
The lower correlation with SGRQ observed in milder
patients could reflect some loss in sensitivity in this
subset of patients, a known characteristic of
shorter questionnaires, called ceiling effect.8,10,12
However, due to power limitations, a definitive
conclusion cannot be made, and this question
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size.
It is desirable, when defining the characteristics
of a new instrument, to know how it correlates with
commonly used outcomes. Correlations of AQ20
and FEV1, FEV1/FVC, SpO2, BMI and SEC were non-
significant, for the whole sample analysis, but this
may have occurred because of an insufficient
sample size to detect such correlations, and this
is a limitation of this study. As far as we know, there
is no previously published study that has studied
the possibility of significant correlation of AQ20 and
FEV1 or hyperinflation parameters in COPD pa-
tients.10 In one study, a weak correlation between
the changes in both AQ20 scores and the FEV1 after
medical treatment in asthmatics was found
(r ¼ 0:40; Po0:05).12 In another study (also in
asthmatic patients), a significant correlation of
AQ20 and peak flow (morning peak flow: r ¼ 0:30;
evening peak flow: r ¼ 0:29), but not with FEV1,11
has been seen.
In this study, dyspnea was evaluated with the
BDI, an instrument that has shown to correlate with
FEV1 (r ¼ 0:41), FVC (r ¼ 0:56) and the distance
walked in 12min (r ¼ 0:60).23 The BDI is usually
used to assess the impact of interventions like
pulmonary rehabilitation24–26 but has also been
used in studies of bronchodilator response in COPD
patients.27 In this study, a statistical significant
correlation with AQ20 was found, which is the first
time that such a correlation has been shown. The
strength of the correlation varied between 0.36
and 0.64. This variability may have been due to
poor reproducibility of BDI in this study
(ICCC ¼ 0:37; Po0:01). In other studies, AQ20 has
been shown to correlate with dyspnea, when
measured by the Oxygen Cost Diagram (r ¼ 0:60;
Po0:005).10Limitations of the study
The influence of gender distribution found in the
sample studied may reflect the gender bias in
diagnosing COPD, mentioned in the literature.28 It
is known that women now suffer from COPD at least
as commonly as men, and they seem to be more
predisposed to suffer the adverse respiratory
consequences of tobacco smoking with the devel-
opment of COPD at an earlier age and with a
greater degree of lung function impairment for a
given amount of tobacco exposure, but COPD is
much more diagnosed in men, due to historical
reasons.28 There is no previous study, to our
knowledge, that has addressed gender differences
in health status in COPD patients. The presentstudy was not designed to detect gender differ-
ences in health status (the sample size had no
power to detect them), but there was no difference
between AQ20 and SGRQ means, when men were
compared to women. Although it cannot be con-
cluded whether a true difference in health status
sex exists, there is no evidence to expect gender
differences in the reproducibility or construct
validity in the AQ20, although this issue could be
further evaluated in another study.Conclusion
We conclude that the Brazilian Portuguese version
of the AQ20 is a specific health status questionnaire
for COPD, being short and quick to complete.
Despite its simplicity, we have demonstrated that
AQ20 has very good reproducibility and correlations
with more complex measures of health status and
dyspnea. More studies are necessary to determine
the minimal clinical significance and normal values
for a COPD population, as well as its response to
interventions in COPD patients.References
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